Current Issue

Jun 2022View Current Issue

Associating liver partition and portal vein ligation (ALPPS) is nowadays an established surgical strategy for patients with liver tumors who are not amenable for upfront hepatectomy because of a too small future liver remnant (FLR) (1).
In these patients, we proposed a new technical variant of ALPPS, called parenchyma sparing ALPPS, consisting in shifting the transection plane though segment 4 (instead of the falciform ligament), thus increasing the FLR (2). The transection plane was established and performed under guidance of intraoperative ultrasound, ensuring oncological m....[more]
Colorectal Surgery During the First Wave of Covid-19 Pandemic: How the Coronavirus Affected Our Practice
Alexandra Manuela Melo de Araújo Antunes, Olga Manuela Duarte Correia de Oliveira, Carlos Casimiro da Costa Pereira, Nuno Miguel Afonso Vilela Pinto, Sandra de Fátima Fernandes Martin, Fernanda Maria da Costa Nogueira, Joaquim Manuel da Costa Pereira
ORIGINAL PAPER, Jun 2022
Article DOI: 10.21614/sgo-475
Read article Objective: The COVID-19 has quickly climbed to a global pandemic and hospitals had to adjust in order to manage the resources available. The aim of this article was to expose our experience and the means used to avoid delay in treating oncologic patients.

Methods: Collection of data from all patient who underwent elective colorectal surgery for neoplasia during the state of emergency (between March 16th and May 16th 2020) and compared the surgical outcomes with the outcomes of the previous year.

Results: A total of 28 patients received col....[more]
Risk Factors for Mortality in Cases of Obstructed Left Colonic Carcinoma
Abdelghafar Abo Elrish, Asharf Abbas, Mokhtar Farid, Mohamed Shetiwy, Mohamed Elsaeed Abdu Mohamed, Magdy Basheer, and Abdelrahman Albahy
ORIGINAL PAPER, Jun 2022
Article DOI: 10.21614/sgo- 463
Read article Background: Emergency surgery for colon cancer is associated with high morbidity and mortality rates. Herein, this study was conducted to estimate the incidence and to detect the risk factors leading to mortality in cases of obstructed left colonic carcinoma.

Methods: This prospective research included 150 patients diagnosed with obstructed left colon cancer and underwent surgical intervention. Based on the incidence of early mortality, they were divided into two groups; the survival and the deceased ones.

Results: Mortality was encountered ....[more]
Evaluation of Adjuvant Short CAPOX Followed by Capecitabine for Stage III Colon Cancer
Eman S. El. Banna, Marwa M. Hussein, Yahia M. Ismail, Ghada M. Sherif, Mostafa M. El.Serafi
ORIGINAL PAPER, Jun 2022
Article DOI: 10.21614/sgo-358
Read article Background: Since 2004, 6 months of postsurgical adjuvant chemotherapy with combination of 5-FU/LV or oral Capecitabine and Oxaliplatin has been the standard of care worldwide for patients with stage III colon cancer. Objectives: to evaluate the efficacy of 3-months of Capecitabine and Oxaliplatin (CAPOX) followed by 3 months Capecitabine alone as adjuvant treatment in stage III colon cancer.

Methods: This is a prospective study that included 50 patients with stage III colon cancer who presented to National Cancer Institute, Cairo University to receive adj....[more]
Implications of Bacteriological Study in Perforated Peptic Ulcer Peritonitis
Sorin Cimpean, Alberto Gonzalez Barranquero, Benjamin Cadiere, Guy-Bernard Cadiere
ORIGINAL PAPER, Jun 2022
Article DOI: 10.21614/sgo-473
Read article Background: In the setting of perforated peptic ulcer (PPU) peritonitis, empiric antimicrobial therapy is initiated perioperatively and adapted according to the culture sensitivity. The aim of the study is to describe the microbiota found in the peritonitis due to a PPU, and to evaluate the predictors for bacterial or fungal infection.

Material and methods: We performed a single-centre, retrospective observational study of all consecutive patients who presented with PPU peritonitis and underwent emergent surgery in Saint Pierre University Hospital, Brussel....[more]
Search The Journal

Video Abstracts


For Authors



Journal Subscriptions

Current Issue

Jun 2022

Supplements

Instructions for authors
Online submission
Contact
ISSN: 2559 - 723X (print)

e-ISSN: 2601 - 1700 (online)

ISSN-L: 2559 - 723X

Journal Abbreviation: Surg. Gastroenterol. Oncol.

Surgery, Gastroenterology and Oncology (SGO) is indexed in:
  • SCOPUS
  • EBSCO
  • DOI/Crossref
  • Google Scholar
  • SCImago
  • Harvard Library
  • Open Academic Journals Index (OAJI)

Journal Metrics

Time to first editorial decision: 25 days
Rejection rate: 61%
CiteScore: 0.2



Meetings and Courses in 2022
Meetings and Courses in 2021
Meetings and Courses in 2020
Meetings and Courses in 2019
Verona expert meeting 2019
Creative Commons License
Surgery, Gastroenterology and Oncology applies the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits readers to copy and redistribute the material in any medium or format, remix, adapt, build upon the published works non-commercially, and license the derivative works on different terms, provided the original material is properly cited and the use is non-commercial. Please see: https://creativecommons.org/licenses/by-nc/4.0/